Subgroup analysis: application to individual patient decisions

This publication has 15 references indexed in Scilit:

• Subgroup analysis in clinical trials
  The Medical Journal of Australia, 2004
• Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study
  American Heart Journal, 2003
• Statistics Notes: Interaction revisited: the difference between two estimates
  BMJ, 2003
• Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials
  American Heart Journal, 2003
• Reporting Number Needed to Treat and Absolute Risk Reduction in Randomized Controlled Trials
  JAMA, 2002
• Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial
  The Lancet, 2001
• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
  The Lancet, 2001
• Statistics Notes: Interaction 2: compare effect sizes not P values
  BMJ, 1996
• Statistics Notes: Interaction 1: heterogeneity of effects
  BMJ, 1996
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994